Log in
Enquire now
‌

US Patent 7473784 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors

Patent 7473784 was granted and assigned to Bristol-Myers Squibb on January, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7473784
Date of Patent
January 6, 2009
Patent Application Number
11494234
Date Filed
July 27, 2006
Patent Citations Received
‌
US Patent 12103926 Compounds for treating huntington's disease
0
‌
US Patent 11780839 Compounds for treating Huntington's disease
‌
US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease
0
Patent Primary Examiner
‌
Laura L. Stockton
Patent abstract

A compound of Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7473784 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.